Autologous mesenchymal stromal cell transplantation for spinal cord injury: A Phase I pilot study

This pilot study demonstrated that autologous MSCs can be safely administered through intrathecal injection in spinal cord injury patients. Further investigation through randomized, placebo-controlled trials is needed.